A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients

Journal of Affective Disorders

Volumn 155, Issue 1, 2014, Pages 216-222

  Shahmansouri, Nazila ^a   Farokhnia, Mehdi ^b   Abbasi, Seyed Hesammeddin ^a,c   Kassaian, Seyed Ebrahim ^a   Noorbala Tafti, Ahmad Ali ^b   Gougol, Amirhossein ^b   Yekehtaz, Habibeh ^b   Forghani, Saeedeh ^d   Mahmoodian, Mehran ^a   Saroukhani, Sepideh ^a   Arjmandi Beglar, Akram ^a   Akhondzadeh, Shahin ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Iranian Petroleum Industry Health Research Institute   (Iran)

^d RAZI VACCINE AND SERUM RESEARCH INSTITUTE   (Iran)

Author keywords

Clinical trial; Crocus sativus L.; Depression; Percutaneous coronary intervention; Saffron

Indexed keywords

CROCUS SATIVUS EXTRACT; FLUOXETINE; PLACEBO; SAFFROMOOD; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; CROCUS SATIVUS; DECREASED APPETITE; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAMILTON SCALE; HUMAN; MALE; MIDDLE AGED; NERVOUSNESS; NEUROLOGIC DISEASE; PARALLEL DESIGN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT DURATION; TREATMENT RESPONSE; XEROSTOMIA; YOUNG ADULT;

CLINICAL TRIAL; CROCUS SATIVUS L.; DEPRESSION; PERCUTANEOUS CORONARY INTERVENTION; SAFFRON;

ANTIDEPRESSIVE AGENTS; CROCUS; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PHYTOTHERAPY; PLANT EXTRACTS; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84891882313     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.11.003     Document Type: Article

References (56)

1. A.S. Ahmad, M.A. Ansari, M. Ahmad, S. Saleem, S. Yousuf, M.N. Hoda, and F. Islam Neuroprotection by crocetin in a hemi-parkinsonian rat model Pharmacol. Biochem. Behav. 81 2005 805 813
2. S. Akhondzadeh, L. Kashani, A. Fotouhi, I.S. Jarvand, M. Mobaseri, M. Moin, M. Khani, A.H. Jamshidi, K. Baghalian, and M. Taghizadeh Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial Prog. Neuropsychopharmacolog. Biol. Psychiatry 27 2003 123 127
3. A. Akhondzadeh Basti, E. Moshiri, A.A. Noorbala, A.H. Jamshidi, S.H. Abbasi, and S. Akhondzadeh Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial Prog. Neuropsychopharmacolog. Biol. Psychiatry 31 2007 439 442
4. S. Akhondzadeh, H. Fallah-Pour, K. Afkham, A.H. Jamshidi, and F. Khalighi-Cigaroudi Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816] BMC Complement. Altern. Med. 4 2004 12
5. S. Akhondzadeh, M.S. Sabet, M.H. Harirchian, M. Togha, H. Cheraghmakani, S. Razeghi, S. Hejazi, M.H. Yousefi, R. Alimardani, A. Jamshidi, F. Zare, and A. Moradi Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial J. Clin. Pharm. Ther. 35 2010 581 588
6. S. Akhondzadeh, M. Shafiee Sabet, M.H. Harirchian, M. Togha, H. Cheraghmakani, S. Razeghi, S.S. Hejazi, M.H. Yousefi, R. Alimardani, A. Jamshidi, S.A. Rezazadeh, A. Yousefi, F. Zare, A. Moradi, and A. Vossoughi A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease Psychopharmacology (Berl) 207 2010 637 643
7. S. Akhondzadeh, N. Tahmacebi-Pour, A.A. Noorbala, H. Amini, H. Fallah-Pour, A.H. Jamshidi, and M. Khani Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial Phytother. Res. 19 2005 148 151
8. W. Alvarez Jr., and K.K. Pickworth Safety of antidepressant drugs in the patient with cardiac disease: a review of the literature Pharmacotherapy 23 2003 754 771
9. C. Andrade Drug interactions in the treatment of depression in patients with ischemic heart disease J. Clin. Psychiatry 73 2012 e1475 e1477
10. J.C. Barefoot, M.J. Helms, D.B. Mark, J.A. Blumenthal, R.M. Califf, T.L. Haney, C.M. O'Connor, I.C. Siegler, and R.B. Williams Depression and long-term mortality risk in patients with coronary artery disease Am. J. Cardiol. 78 1996 613 617
11. S.Z. Bathaie, and S.Z. Mousavi New applications and mechanisms of action of saffron and its important ingredients Crit. Rev. Food Sci. Nutr. 50 2010 761 786
12. H. Baumeister, N. Hutter, and J. Bengel Psychological and pharmacological interventions for depression in patients with coronary artery disease Cochrane Database Syst. Rev. 2011 (CD008012)
13. F. Berger, A. Hensel, and K. Nieber Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices Neuroscience 180 2011 238 247
14. L.F. Berkman, J. Blumenthal, M. Burg, R.M. Carney, D. Catellier, M.J. Cowan, S.M. Czajkowski, R. DeBusk, J. Hosking, A. Jaffe, P.G. Kaufmann, P. Mitchell, J. Norman, L.H. Powell, J.M. Raczynski, and N. Schneiderman Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial JAMA 289 2003 3106 3116
15. J.T. Bigger, and A.H. Glassman The American Heart Association science advisory on depression and coronary heart disease: an exploration of the issues raised Cleve Clin. J. Med. 77 Suppl. 3 2010 S12 S19
16. R.M. Carney, and K.E. Freedland Depression in patients with coronary heart disease Am. J. Med. 121 2008 S20 S27
17. R. Fielding Depression and acute myocardial infarction: a review and reinterpretation Soc. Sci. Med. 32 1991 1017 1028
18. S.N. Goyal, S. Arora, A.K. Sharma, S. Joshi, R. Ray, J. Bhatia, S. Kumari, and D.S. Arya Preventive effect of crocin of Crocus sativus on hemodynamic, biochemical, histopathological and ultrastuctural alterations in isoproterenol-induced cardiotoxicity in rats Phytomedicine 17 2010 227 232
19. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
20. S.Y. He, Z.Y. Qian, F.T. Tang, N. Wen, G.L. Xu, and L. Sheng Effect of crocin on experimental atherosclerosis in quails and its mechanisms Life Sci. 77 2005 907 921
21. H. Hosseinzadeh, and M. Nassiri-Asl Avicenna's (Ibn Sina) the Canon of medicine and saffron (Crocus sativus): a review Phytother. Res. 27 2013 475 483
22. M. Imenshahidi, H. Hosseinzadeh, and Y. Javadpour Hypotensive effect of aqueous saffron extract (Crocus sativus L.) and its constituents, safranal and crocin, in normotensive and hypertensive rats Phytother. Res. 24 2010 990 994
23. L. Jespersen, S.Z. Abildstrom, A. Hvelplund, and E. Prescott Persistent angina: highly prevalent and associated with long-term anxiety, depression, low physical functioning, and quality of life in stable angina pectoris Clin. Res. Cardiol. 102 2013 571 581
24. S. Joukar, H. Najafipour, M. Khaksari, G. Sepehri, N. Shahrokhi, S. Dabiri, A. Gholamhoseinian, and S. Hasanzadeh The effect of saffron consumption on biochemical and histopathological heart indices of rats with myocardial infarction Cardiovasc. Toxicol. 10 2010 66 71
25. M. Kamalipour, and S. Akhondzadeh Cardiovascular effects of saffron: an evidence-based review J. Tehran Heart Cent. 6 2011 59 61
26. L. Kashani, F. Raisi, S. Saroukhani, H. Sohrabi, A. Modabbernia, A.A. Nasehi, A. Jamshidi, M. Ashrafi, P. Mansouri, P. Ghaeli, and S. Akhondzadeh Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study Hum. Psychopharmacol. 28 2013 54 60
27. F. Lesperance, and N. Frasure-Smith Depression in patients with cardiac disease: a practical review J. Psychosom. Res. 48 2000 379 391
28. F. Lesperance, N. Frasure-Smith, M. Juneau, and P. Theroux Depression and 1-year prognosis in unstable angina Arch. Intern. Med. 160 2000 1354 1360
29. N. Mavrides, and C. Nemeroff Treatment of depression in cardiovascular disease Depress Anxiety 30 2013 328 341
30. R. Mehdizadeh, M.R. Parizadeh, A.R. Khooei, S. Mehri, and H. Hosseinzadeh Cardioprotective effect of saffron extract and safranal in isoproterenol- induced myocardial infarction in wistar rats Iran. J. Basic Med. Sci. 16 2013 56 63
31. A. Meijer, H.J. Conradi, E.H. Bos, B.D. Thombs, J.P. van Melle, and P. de Jonge Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research Gen. Hosp. Psychiatry 33 2011 203 216
32. A. Modabbernia, H. Sohrabi, A.A. Nasehi, F. Raisi, S. Saroukhani, A. Jamshidi, M. Tabrizi, M. Ashrafi, and S. Akhondzadeh Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial Psychopharmacol. (Berl) 223 2012 381 388
33. M.H. Modaghegh, M. Shahabian, H.A. Esmaeili, O. Rajbai, and H. Hosseinzadeh Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers Phytomedicine 15 2008 1032 1037
34. P. Montoro, M. Maldini, L. Luciani, C.I. Tuberoso, F. Congiu, and C. Pizza Radical scavenging activity and LC-MS metabolic profiling of petals, stamens, and flowers of Crocus sativus L J. Food Sci. 77 2012 C893 C900
35. E. Moshiri, A.A. Basti, A.A. Noorbala, A.H. Jamshidi, S. Hesameddin Abbasi, and S. Akhondzadeh Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial Phytomedicine 13 2006 607 611
36. A.A. Noorbala, S. Akhondzadeh, N. Tahmacebi-Pour, and A.H. Jamshidi Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial J. Ethnopharmacol. 97 2005 281 284
37. M.A. Papandreou, M. Tsachaki, S. Efthimiopoulos, P. Cordopatis, F.N. Lamari, and M. Margarity Memory enhancing effects of saffron in aged mice are correlated with antioxidant protection Behav. Brain Res. 219 2011 197 204
38. M.W. Park, J.H. Kim, S.H. Her, J.S. Cho, M.S. Choi, T.G. Gweon, I.N. Ju, J.Y. Baek, K.B. Seung, and H. Go Effects of percutaneous coronary intervention on depressive symptoms in chronic stable angina patients Psychiatry Invest. 9 2012 252 256
39. N. Pitsikas, S. Zisopoulou, P.A. Tarantilis, C.D. Kanakis, M.G. Polissiou, and N. Sakellaridis Effects of the active constituents of Crocus sativus L., crocins on recognition and spatial rats' memory Behav. Brain Res. 183 2007 141 146
40. C. Pizzi, A.W. Rutjes, G.M. Costa, F. Fontana, A. Mezzetti, and L. Manzoli Meta-analysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease Am. J. Cardiol. 107 2011 972 979
41. J.C. Roos Cardiac effects of antidepressant drugs. A comparison of the tricyclic antidepressants and fluvoxamine Br. J. Clin. Pharmacol. 15 Suppl. 3 1983 439S 445S
42. J. Sachdeva, V. Tanwar, M. Golechha, K.M. Siddiqui, T.C. Nag, R. Ray, S. Kumari, and D.S. Arya Crocus sativus L. (saffron) attenuates isoproterenol-induced myocardial injury via preserving cardiac functions and strengthening antioxidant defense system Exp. Toxicol. Pathol. 64 2012 557 564
43. M. Schmidt, G. Betti, and A. Hensel Saffron in phytotherapy: pharmacology and clinical uses Wien. Med. Wochenschr. 157 2007 315 319
44. J. Serrano-Diaz, A.M. Sanchez, L. Maggi, M. Martinez-Tome, L. Garcia-Diz, M.A. Murcia, and G.L. Alonso Increasing the applications of Crocus sativus flowers as natural antioxidants J. Food Sci. 77 2012 C1162 C1168
45. L. Sheng, Z. Qian, S. Zheng, and L. Xi Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase Eur. J. Pharmacol. 543 2006 116 122
46. S. Shirali, S. Zahra Bathaie, and M. Nakhjavani Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats Phytother. Res. 27 2013 1042 1047
47. T.C. Somberg, and R.R. Arora Depression and heart disease: therapeutic implications Cardiology 111 2008 75 81
48. R. Srivastava, H. Ahmed, R.K. Dixit, Dharamveer, and S.A. Saraf Crocus sativus L.: a comprehensive review Pharmacogn. Rev. 4 2010 200 208
49. L. Stafford, M. Berk, P. Reddy, and H.J. Jackson Comorbid depression and health-related quality of life in patients with coronary artery disease J. Psychosom. Res. 62 2007 401 410
50. K.M. Summers, K.E. Martin, and K. Watson Impact and clinical management of depression in patients with coronary artery disease Pharmacotherapy 30 2010 304 322
51. W. Swardfager, N. Herrmann, S. Marzolini, M. Saleem, S.B. Farber, A. Kiss, P.I. Oh, and K.L. Lanctot Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease J. Clin. Psychiatry 72 2011 1181 1188
52. C.B. Taylor, M.E. Youngblood, D. Catellier, R.C. Veith, R.M. Carney, M.M. Burg, P.G. Kaufmann, J. Shuster, T. Mellman, J.A. Blumenthal, R. Krishnan, and A.S. Jaffe Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction Arch. Gen. Psychiatry 62 2005 792 798
53. C. Ulbricht, J. Conquer, D. Costa, W. Hollands, C. Iannuzzi, R. Isaac, J.K. Jordan, N. Ledesma, C. Ostroff, J.M. Serrano, M.D. Shaffer, and M. Varghese An evidence-based systematic review of saffron (Crocus sativus) by the natural standard research collaboration J. Diet. Suppl. 8 2011 58 114
54. Y. Wang, T. Han, Y. Zhu, C.J. Zheng, Q.L. Ming, K. Rahman, and L.P. Qin Antidepressant properties of bioactive fractions from the extract of Crocus sativus L J. Nat. Med. 64 2010 24 30
55. G.Y. Yeh, R.B. Davis, and R.S. Phillips Use of complementary therapies in patients with cardiovascular disease Am. J. Cardiol. 98 2006 673 680
56. S. Zheng, Z. Qian, F. Tang, and L. Sheng Suppression of vascular cell adhesion molecule-1 expression by crocetin contributes to attenuation of atherosclerosis in hypercholesterolemic rabbits Biochem. Pharmacol. 70 2005 1192 1199